Swiss pharma giant Novartis on Friday revealed plans to build its fourth US radioligand therapy (RLT) manufacturing facility ...
US pharma Madrigal Pharmaceuticals, which is focused on delivering novel therapeutics for metabolic dysfunction-associated ...
Shares of US cancer drug Revolution Medicines, with a market capitalization of more than $20 billion, rose nearly 29% following reports of a buyout from US pharma giant Merck & Co.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback